Atlas Trials

A Trial to Evaluate the Efficacy, Safety and Tolerability of Subcutaneous TRV250

Clinical trial NCT04201080 · TERMINATED

Trial details

NCT number
NCT04201080
Sponsor
Trevena Inc.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Migraines
Start date
2019-11-11
Primary completion
2020-02-17
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.